Coal India Merger & Restructuring Worth ₹0.1 Cr

Coal India Investor Presentation: Key Takeaways

Q2 FY27 consolidated PAT ₹6,547 Cr (+57%), revenue ₹44,179 Cr (+21%), EBITDA margin 26%; H1 PAT ₹15,397 Cr (+19%). Production -2% in H1; offtake +8%.

Coal India Dividend

Coal India declared a second interim dividend of Rs 10.25 per share for FY 2026-27 with record date 4 November 2026. Payment will be made by 27 November 2026 through electronic modes only.

Coal India Financial Results

Coal India reported unaudited Q2 and half-year results and declared a ₹10.25 per share second interim dividend. Record date is November 4, 2026.

Coal India Business Update

Coal India spent ₹7,966 crore on capex in H1 FY27, a 27% YoY rise. The outlay achieved 109% of the planned target for the period.

Coal India Board Meeting Date

Coal India will hold a board meeting on 29 October 2026 to consider Q2/H1 2026 results and possible interim dividend. No financial figures are disclosed.

Coal India Other Announcement

Coal India Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine periodic regulatory disclosure.

Symphony Merger & Restructuring Worth ₹27 Cr

Symphony will sell its Bodakdev vacant land for ₹27 Crore, versus ₹5.68 Crore book value. Sale deed is expected November 6, 2026; operations are unaffected.

Value

₹27.00 Cr

Juniper Green Energy Merger & Restructuring Worth ₹0.15 Cr

Juniper Green Energy incorporated wholly owned subsidiary Juniper Green Beta Fifteen Private Limited on October 30, 2026. The company subscribed to 1,50,000 shares for Rs.0.15 Crore.

Value

₹0.15 Cr

Oricon Enterprises Merger & Restructuring Worth ₹145 Cr

Oricon Enterprises sold its leasehold land and building to Anand Rathi Towers for Rs.145 Crore. The sale is completed and the buyer is unrelated to promoters.

Value

₹145.0 Cr

Clean Max Enviro Energy Solutions Merger & Restructuring Worth ₹0 Cr

Sale of 26% stake in subsidiary Clean Max Alps to Bayer Vapi for ₹0.0026 Crore. The subsidiary contributed no revenue or net worth last financial year.

Value

₹0.00 Cr

Vimta Labs Merger & Restructuring Worth ₹0.08 Cr

Vimta Labs incorporated wholly owned US subsidiary Vimta Labs LLC, investing about INR 0.08 Crore (USD 8,500). The contract research unit supports the parent's testing business.

Value

₹0.08 Cr

Weagro Merger & Restructuring Worth ₹0.01 Cr

Weagro will incorporate a wholly-owned Singapore subsidiary, Weagro Pte Ltd, with initial investment up to SGD 100,000. The move expands its agro business into Singapore.

Value

₹0.01 Cr

Execution

Within two months from the date of the Board decision, subject to statutory approvals.